Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | TSPO | P30536 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.38 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.37 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.37 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.37 |
| ▸ | PTGES2 | Q9H7Z7 | 4/20 | 0.36 |
| ▸ | PTGES | O14684 | 1/20 | 0.36 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30256945 | 1.00 | DNM1 (0.46) | DNM1CYP1A2TSPOKDM4EATM | |
| SCHEMBL22876321 | 0.96 | CYP1A2 (0.46) | DNM1CYP1A2KDM4EALDH1A1MAP4K4 | |
| SCHEMBL22876181 | 0.96 | CYP1A2 (0.46) | DNM1CYP1A2KDM4EALDH1A1MAP4K4 | |
| SCHEMBL22876298 | 0.93 | ATM (0.44) | DNM1TSPOKDM4EATML3MBTL1 | |
| SCHEMBL25671847 | 0.93 | ATM (0.44) | DNM1TSPOKDM4EATML3MBTL1 | |
| SCHEMBL22876426 | 0.93 | ATM (0.44) | DNM1TSPOKDM4EATML3MBTL1 | |
| SCHEMBL30257589 | 0.92 | DNM1 (0.46) | DNM1CYP1A2TSPOKDM4EATM | |
| SCHEMBL27012159 | 0.92 | DNM1 (0.43) | DNM1CYP1A2KDM4EATML3MBTL1 | |
| SCHEMBL25583853 | 0.92 | CYP1A2 (0.40) | DNM1CYP1A2KDM4EL3MBTL1MAP4K4 | |
| SCHEMBL31592719 | 0.91 | KDM4E (0.46) | DNM1TSPOKDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11111231-B2 | Heterocyclic compound and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2021-09-07 | — | — | US | disclosed |
| EP-3015465-B1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEMICAL LTD (KR) | 2019-09-04 | — | — | EP | disclosed |
| US-20190127352-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2019-05-02 | — | — | US | disclosed |
| US-10253016-B2 | Heterocyclic compound and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2019-04-09 | — | — | US | disclosed |
| US-20160204359-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2016-07-14 | — | — | US | disclosed |
| US-20160204359-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2016-07-14 | — | — | US | disclosed |
| EP-3015465-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG Chem, Ltd. (KR) | 2016-05-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10253016-B2 | Heterocyclic compound and organic light-emitting device comprising same | CRY1, CRY2, NR2E3 | DNM1 3462/4885CYP1A2 53/4885TSPO 2299/4885 |
| US-20160204359-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CRY1, CRY2, NR2E3 | DNM1 3462/4885CYP1A2 53/4885TSPO 2299/4885 |
| US-11111231-B2 | Heterocyclic compound and organic light-emitting device comprising same | CRY1, CRY2, NR2E3 | DNM1 3462/4885CYP1A2 53/4885TSPO 2299/4885 |
| US-20190127352-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CRY1, CRY2, NR2E3 | DNM1 3462/4885CYP1A2 53/4885TSPO 2299/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.